Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Previously Untreated Gastric Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT05568095
What this trial is testing

A Clinical Trial of a New Combination Treatment, Domvanalimab and Zimberelimab, Plus Chemotherapy, for People With an Upper Gastrointestinal Tract Cancer That Cannot be Removed With Surgery That Has Spread to Other Parts of the Body

Who this might be right for
Advanced Upper Gastrointestinal Tract Adenocarcinoma
Arcus Biosciences, Inc. 1,040
Large-scale testing (Phase 3)Study completedNCT00020787
What this trial is testing

Vaccine Therapy Plus Chemotherapy in Treating Patients With Metastatic or Locally Recurrent Stomach Cancer or Esophageal Cancer

Who this might be right for
Esophageal CancerGastric Cancer
Jonsson Comprehensive Cancer Center 8
Testing effectiveness (Phase 2)Study completedNCT00042510
What this trial is testing

Safety and Efficacy of G17DT Immunogen in the Treatment of Gastric and Gastroesophageal Cancer

Who this might be right for
Stomach NeoplasmsEsophageal Neoplasms
Cancer Advances Inc. 103
Large-scale testing (Phase 3)Study completedNCT02872116
What this trial is testing

Efficacy Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Against Chemotherapy in Stomach Cancer or Stomach/Esophagus Junction Cancer

Who this might be right for
Gastric CancerGastroesophageal Junction CancerEsophageal Adenocarcinoma
Bristol-Myers Squibb 2,031
Testing effectiveness (Phase 2)Looking for participantsNCT07432295
What this trial is testing

Givastomig Combined With Nivolumab and Chemotherapy in Adults With CLDN18.2 Positive Metastatic Gastric Cancer (GIVA-2)

Who this might be right for
Solid TumorAdvanced CancerMetastatic Cancer+3 more
I-Mab Biopharma US Limited 180
Large-scale testing (Phase 3)Ended earlyNCT05111626
What this trial is testing

Bemarituzumab Plus Chemotherapy and Nivolumab Versus Chemotherapy and Nivolumab for FGFR2b Overexpressed Untreated Advanced Gastric and Gastroesophageal Junction Cancer.

Who this might be right for
Gastric CancerGastroesophageal Junction Adenocarcinoma
Amgen 515
Testing effectiveness (Phase 2)Looking for participantsNCT07315854
What this trial is testing

Iparomlimab and Tuvonralimab (QL1706) Combined With Chemotherapy for Previously Untreated Advanced or Metastatic Gastric or Gastroesophageal Junction Cancer

Who this might be right for
Gastric Cancer (GC)Gastroesophageal Junction CancerAdvanced Gastric Cancer+1 more
Beijing Friendship Hospital 32
Testing effectiveness (Phase 2)UnknownNCT00510107
What this trial is testing

Weekly Docetaxel Plus Cisplatin or Oxaliplatin for AGC

Who this might be right for
Stomach NeoplasmStage IVRecurrent
Gachon University Gil Medical Center 90
Large-scale testing (Phase 3)Study completedNCT00811447
What this trial is testing

Taxotere New Indication - Gastric Cancer Treatment Registration Trial

Who this might be right for
Stomach Neoplasms
Sanofi 243
Large-scale testing (Phase 3)Study completedNCT00538850
What this trial is testing

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Who this might be right for
Cancer
INSYS Therapeutics Inc 130
Testing effectiveness (Phase 2)Study completedNCT00453102
What this trial is testing

Yttrium Y 90 Ibritumomab Tiuxetan and Rituximab in Treating Patients With Previously Untreated Marginal Zone Lymphoma

Who this might be right for
Marginal Zone Lymphoma
University of Miami 18
Large-scale testing (Phase 3)WithdrawnNCT04859582
What this trial is testing

Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Participants Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-859/KEYNOTE-859)-China Extension

Who this might be right for
Stomach Neoplasms
Merck Sharp & Dohme LLC
Early research (Phase 1)Study completedNCT01643499
What this trial is testing

Genotype-guided Dosing of mFOLFIRINOX Chemotherapy in Patients With Previously Untreated Advanced Gastrointestinal Malignancies

Who this might be right for
Acinar Cell Adenocarcinoma of the PancreasAdenocarcinoma of the GallbladderAdenocarcinoma of Unknown Primary+37 more
University of Chicago 79
Large-scale testing (Phase 3)Ended earlyNCT01285557
What this trial is testing

Diffuse Gastric and Esophagogastric Junction Cancer S-1 Trial

Who this might be right for
Metastatic Diffuse Gastric Cancer Including Carcinoma of the Gastro-esophageal Junction
Taiho Oncology, Inc. 361
Testing effectiveness (Phase 2)Ended earlyNCT05322577
What this trial is testing

A Study Evaluating Bemarituzumab in Combination With Other Anti-cancer Therapies in Subjects With Previously Untreated Advanced Gastric or Gastroesophageal Junction Cancer.

Who this might be right for
Gastric CancerGastroesophageal Junction Cancer
Amgen 72
Testing effectiveness (Phase 2)Study completedNCT02370849
What this trial is testing

Cisplatin and S-1 With or Without Nimotuzumab in Untreated Advanced Gastric Adenocarcinoma

Who this might be right for
Stomach Neoplasms
Chinese Academy of Medical Sciences 2
Early research (Phase 1)Study completedNCT03343301
What this trial is testing

Bemarituzumab (FPA144) Combined With Modified FOLFOX6 in Gastric/Gastroesophageal Cancer

Who this might be right for
Gastrointestinal CancerGastrointestinal Cancer MetastaticGastric Cancer
Five Prime Therapeutics, Inc. 12
Early research (Phase 1)Study completedNCT00161187
What this trial is testing

Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor

Who this might be right for
Cancer
University of Medicine and Dentistry of New Jersey 37
Testing effectiveness (Phase 2)Study completedNCT03647969
What this trial is testing

Modified FOLFOX Plus/Minus Nivolumab and Ipilimumab vs. FLOT Plus Nivolumab in Patients With Previously Untreated Advanced or Metastatic Gastric Cancer

Who this might be right for
Adenocarcinoma of the StomachGastroEsophageal Cancer
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 262
Testing effectiveness (Phase 2)Study completedNCT03694522
What this trial is testing

Bemarituzumab (FPA144) Combined With Modified FOLFOX6 (mFOLFOX6) in Gastric/Gastroesophageal Junction Cancer

Who this might be right for
Gastric Cancer
Five Prime Therapeutics, Inc. 155
Next Page